Small molecule mesengenic induction of human induced pluripotent stem cells to generate mesenchymal stem/stromal cells

Stem Cells Translational Medicine

Volumn 1, Issue 2, 2012, Pages 83-95

  Chen, Yen Shun ^a   Pelekanos, Rebecca A ^a   Ellis, Rebecca L ^a   Horne, Rachel ^b   Wolvetang, Ernst J ^b   Fisk, Nicholas M ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Differentiation; Embryonic stem cells; Induced pluripotent stem cells; Mesenchymal stem cells; Pluripotent stem cells

Indexed keywords

4 [4 (1, 3 BENZODIOXOL 5 YL) 5 (2 PYRIDINYL) 1H IMIDAZOL 2 YL] BENZAMIDE; 5' NUCLEOTIDASE; BETA1 INTEGRIN; BONE MORPHOGENETIC PROTEIN 4; CD24 ANTIGEN; ENDOGLIN; HERMES ANTIGEN; LEFT RIGHT DETERMINATION FACTOR; NERVE CELL ADHESION MOLECULE; OCTAMER TRANSCRIPTION FACTOR 4; SMAD2 PROTEIN; SMAD3 PROTEIN; THY 1 ANTIGEN; TRANSCRIPTION FACTOR CDX2; TRANSCRIPTION FACTOR GATA 2; TRANSCRIPTION FACTOR MSX2; TRANSCRIPTION FACTOR PAX6; TRANSCRIPTION FACTOR SOX17; TRANSCRIPTION FACTOR SOX2; TRANSCRIPTION FACTOR SOX7; TRANSCRIPTION FACTOR TWIST; TRANSCRIPTION FACTOR ZEB1; UNCLASSIFIED DRUG; VIMENTIN;

ADULT; ANIMAL EXPERIMENT; ARTICLE; CELL DIFFERENTIATION; CELL KINETICS; CELL PROLIFERATION; CELL SURVIVAL; EMBRYOID BODY; EMBRYONIC STEM CELL; EPITHELIAL MESENCHYMAL TRANSITION; FETUS; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; IMMUNOFLUORESCENCE TEST; KARYOTYPING; MESENCHYMAL STROMA CELL; MORPHOLOGY; MOUSE; NONHUMAN; OSTEOBLAST; PHASE CONTRAST MICROSCOPY; PLURIPOTENT STEM CELL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TERATOMA; WESTERN BLOTTING;

EID: 84866989355     PISSN: 21576564     EISSN: 21576580     Source Type: Journal    
DOI: 10.5966/sctm.2011-0022     Document Type: Article

References (63)

1. Bieback K, Kern S, Kocaomer A et al. Comparing mesenchymal stromal cells from different human tissues: Bone marrow, adipose tissue and umbilical cord blood. Biomed Mater Eng 2008;18:S71-S76.
2. Kern S, Eichler H, Stoeve J et al. Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. STEM CELLS 2006;24:1294-1301.
3. Stolzing A, Jones E, McGonagle D et al. Age-related changes in human bone marrow derived mesenchymal stem cells: Consequences for cell therapies. Mech Ageing Dev 2008;129:163-173.
4. Zhou S, Greenberger JS, Epperly MW et al. Age-related intrinsic changes in human bone marrow-derived mesenchymal stem cells and their differentiation to osteoblasts. Aging Cell 2008;7:335-343.
5. Guillot PV, Gotherstrom C, Chan J et al. Human first-trimester fetal MSC express pluripotency markers and grow faster and have longer telomeres than adult MSC. STEM CELLS 2007; 25:646-654.
6. Zhang H, Fazel S, Tian H et al. Increasing donor age adversely impacts beneficial effects of bone marrow but not smooth muscle myocardial cell therapy. Am J Physiol Heart Circ Physiol 2005;289:H2089-H2096.
7. Brown SE, Tong W, Krebsbach PH. The derivation of mesenchymal stem cells from human embryonic stem cells. Cells Tissues Organs 2009;189:256-260.
8. Hwang NS, Varghese S, Lee HJ et al. In vivo commitment and functional tissue regeneration using human embryonic stem cell-derived mesenchymal cells. Proc Natl Acad Sc i U S A 2008;105:20641-20646.
9. Barberi T, Willis LM, Socci ND et al. Derivation of multipotent mesenchymal precursors from human embryonic stem cells. PLoS Med 2005;2:e161.
10. Mahmood A, Harkness L, Schroder HD et al. Enhanced differentiation of human embryonic stem cells to mesenchymal progenitors by inhibition of TGF-/activin/nodal signaling using SB-431542. J Bone Miner Res 2010;25: 1216-1233.
11. Olivier EN, Rybicki AC, Bouhassira EE. Differentiation of human embryonic stem cells into bipotent mesenchymal stem cells. STEM CELLS 2006;24:1914-1922.
12. Trivedi P, Hematti P. Simultaneous generation of CD34 primitive hematopoietic cells and CD73mesenchymal stem cells from human embryonic stem cells cocultured with murine OP9 stromal cells. Exp Hematol 2007; 35:146-154.
13. Xu C, Jiang J, Sottile V et al. Immortalized fibroblast-like cells derived from human embryonic stem cells support undifferentiated cell growth. STEM CELLS 2004;22:972-980.
14. Sanchez L, Gutierrez-Aranda I, Ligero G et al. Enrichment of human ESC-derived multipotent mesenchymal stem cells with immunosuppressive and anti-inflammatory properties capable to protect against experimental inflammatory bowel disease. STEM CELLS 2010;29: 251-262.
15. Xu J, Lamouille S, Derynck R. TGF-induced epithelial to mesenchymal transition. Cell Res 2009;19:156-172.
16. Evseenko D, Zhu Y, Schenke-Layland K et al. Mapping the first stages of mesoderm commitment during differentiation of human embryonic stem cells. Proc Natl Acad Sc i U S A 2010;107:13742-13747.
17. Li R, Liang J, Ni S et al. A mesenchymalto-epithelial transition initiates and is required for the nuclear reprogramming of mouse fibroblasts. Cell Stem Cell 2010;7:51-63.
18. Samavarchi-Tehrani P, Golipour A, David L et al. Functional genomics reveals a BMP-driven mesenchymal-to-epithelial transition in the initiation of somatic cell reprogramming. Cell Stem Cell 2010;7:64-77.
19. Boyd NL, Robbins KR, Dhara SK et al. Human embryonic stem cell-derived mesodermlike epithelium transitions to mesenchymal progenitor cells. Tissue Eng Part A 2009;15: 1897-1907.
20. Hannan NR, Jamshidi P, Pera MF et al. BMP-11 and myostatin support undifferentiated growth of human embryonic stem cells in feeder-free cultures. Cloning Stem Cells 2009; 11:427-435.
21. Vallier L, Pedersen RA. Human embryonic stem cells: An in vitro model to study mechanisms controlling pluripotency in early mammalian development. Stem Cell Rev 2005; 1:119-130.
22. Vallier L, Touboul T, Brown S et al. Signaling pathways controlling pluripotency and early cell fate decisions of human induced pluripotent stem cells. STEM CELLS 2009;27:2655-2666.
23. Osakada F, Jin ZB, Hirami Y et al. In vitro differentiation of retinal cells from human pluripotent stem cells by small-molecule induction. J Cell Sci 2009;122:3169-3179.
24. Watabe T, Nishihara A, Mishima K et al. TGF-receptor kinase inhibitor enhances growth and integrity of embryonic stem cellderived endothelial cells. J Cell Biol 2003;163: 1303-1311.
25. Chambers SM, Fasano CA, Papapetrou EP et al. Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling. Nat Biotechnol 2009;27:275-280.
26. Xu RH, Sampsell-Barron TL, Gu F et al. NANOG is a direct target of TGF /activin-mediated SMAD signaling in human ESCs. Cell Stem Cell 2008;3:196-206.
27. Yu J, Vodyanik MA, Smuga-Otto K et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 2007;318: 1917-1920.
28. Reubinoff BE, Pera MF, Fong CY et al. Embryonic stem cell lines from human blastocysts: Somatic differentiation in vitro. Nat Biotechnol 2000;18:399-404.
29. Costa M, Sourris K, Hatzistavrou T et al. Expansion of human embryonic stem cells in vitro. Curr Protoc Stem Cell Biol. 2008;1C.1.1-1C.1.7.
30. Ludwig T, Thomson J. Defined, feederindependent medium for human embryonic stem cell culture. Curr Protoc Stem Cell Biol. 2007;Chapter 1:Unit 1C 2.
31. Dominici M, Le Blanc K, Mueller I et al. Minimal criteria for defining multipotent mesenchymal stromal cells: The International Society for Cellular Therapy position statement. Cytotherapy 2006;8:315-317.
32. Adewumi O, Aflatoonian B, AhrlundRichter L et al. Characterization of human embryonic stem cell lines by the International Stem Cell Initiative. Nat Biotechnol 2007;25: 803-816.
33. Karlsson C, Emanuelsson K, Wessberg F et al. Human embryonic stem cell-derived mesenchymal progenitors: Potential in regenerative medicine. Stem Cell Res. 2009.
34. Barlow S, Brooke G, Chatterjee K et al. Comparison of human placenta-and bone marrow-derived multipotent mesenchymal stem cells. Stem Cells Dev 2008;17:1095-1107.
35. Hsieh JY, Fu YS, Chang SJ et al. Functional module analysis reveals differential osteogenic and stemness potentials in human mesenchymal stem cells from bone marrow and Wharton's jelly of umbilical cord. Stem Cells Dev 2010;19:1895-1910.
36. Kim MJ, Shin KS, Jeon JH et al. Human chorionic-plate-derived mesenchymal stem cells and Wharton's jelly-derived mesenchymal stem cells: A comparative analysis of their potential as placenta-derived stem cells. Cell Tissue Res. 2011;346:53-64.
37. Morganstein DL, Wu P, Mane MR et al. Human fetal mesenchymal stem cells differentiate into brown and white adipocytes: A role for ERR in human UCP1 expression. Cell Res 2010;20:434-444.
38. Rebelatto CK, Aguiar AM, Moretao MP et al. Dissimilar differentiation of mesenchymal stem cells from bone marrow, umbilical cord blood, and adipose tissue. Exp Biol Med (Maywood) 2008;233:901-913.
39. Zhang ZY, Teoh SH, Chong MS et al. Superior osteogenic capacity for bone tissue engineering of fetal compared with perinatal and adult mesenchymal stem cells. STEM CELLS 2009; 27:126-137.
40. Dvash T, Sharon N, Yanuka O et al. Molecular analysis of LEFTY-expressing cells in early human embryoid bodies. STEM CELLS 2007; 25:465-472.
41. Yu P, Pan G, Yu J et al. FGF2 sustains NANOG and switches the outcome of BMP4induced human embryonic stem cell differentiation. Cell Stem Cell 2011;8:326-334.
42. Jiang J, Ng HH. TGF and SMADs talk to NANOG in human embryonic stem cells. Cell Stem Cell 2008;3:127-128.
43. Galvin KE, Travis ED, Yee D et al. Nodal signaling regulates the bone morphogenic protein pluripotency pathway in mouse embryonic stem cells. J Biol Chem 2010;285:19747-19756.
44. Xu RH, Chen X, Li DS et al. BMP4 initiates human embryonic stem cell differentiation to trophoblast. Nat Biotechnol 2002;20:1261-1264.
45. Kim DS, Lee JS, Leem JW et al. Robust enhancement of neural differentiation from human ES and iPS cells regardless of their innate difference in differentiation propensity. Stem Cell Rev 2010;6:270-281.
46. Smith JR, Vallier L, Lupo G et al. Inhibition of Activin/Nodal signaling promotes specification of human embryonic stem cells into neuroectoderm. Dev Biol 2008;313:107-117.
47. James D, Nam HS, Seandel M et al. Expansion and maintenance of human embryonic stem cell-derived endothelial cells by TGF inhibition is Id1 dependent. Nat Biotechnol 2010;28:161-166.
48. Ullmann U, In'T Veld P, Gilles C et al. Epithelial-mesenchymal transition process in human embryonic stem cells cultured in feederfree conditions. Mol Hum Reprod 2007;13:21-32.
49. Kalluri R, Weinberg RA. The basics of epithelial-mesenchymal transition. J Clin Invest 2009;119:1420-1428.
50. Zeisberg M, Neilson EG. Biomarkers for epithelial-mesenchymal transitions. J Clin Invest 2009;119:1429-1437.
51. Ichida JK, Blanchard J, Lam K et al. A small-molecule inhibitor of TGFsignaling replaces sox2 in reprogramming by inducing nanog. Cell Stem Cell 2009;5:491-503.
52. Lin T, Ambasudhan R, Yuan X et al. A chemical platform for improved induction of human iPSCs. Nat Methods 2009;6:805-808.
53. Harrison CA, Gray PC, Vale WW et al. Antagonists of activin signaling: Mechanisms and potential biological applications. Trends Endocrinol Metab 2005;16:73-78.
54. Pera MF, Tam PP. Extrinsic regulation of pluripotent stem cells. Nature 2010;465:713-720.
55. Acloque H, Adams MS, Fishwick K et al. Epithelial-mesenchymal transitions: The importance of changing cell state in development and disease. J Clin Invest 2009;119:1438-1449.
56. Guillot PV, Abass O, Bassett JH et al. Intrauterine transplantation of human fetal mesenchymal stem cells from first-trimester blood repairs bone and reduces fractures in osteogenesis imperfecta mice. Blood 2008;111: 1717-1725.
57. Zhang J, Lian Q, Zhu G et al. A human iPSC model of Hutchinson Gilford Progeria reveals vascular smooth muscle and mesenchymal stem cell defects. Cell Stem Cell 2011;8:31-45.
58. Kluth SM, Buchheiser A, Houben AP et al. DLK-1 as a marker to distinguish unrestricted somatic stem cells and mesenchymal stromal cells in cord blood. Stem Cells Dev 2010;19: 1471-1483.
59. Leskelä HV, Olkku A, Lehtonen S et al. Estrogen receptor genotype confers interindividual variability of response to estrogen and testosterone in mesenchymal-stem-cellderived osteoblasts. Bone 2006;39:1026-1034.
60. Guillot PV, De Bari C, Dell'Accio F et al. Comparative osteogenic transcription profiling of various fetal and adult mesenchymal stem cell sources. Differentiation 2008;76:946-957.
61. Frith JE, Thomson B, Genever PG. Dynamic three-dimensional culture methods enhance mesenchymal stem cell properties and increase therapeutic potential. Tissue Eng Part C Methods 2010;16:735-749.
62. Hudson JE, Mills RJ, Frith JE et al. A defined medium and substrate for expansion of human mesenchymal stromal cell progenitors that enriches for osteo-and chondrogenic precursors. Stem Cells Dev 2011;20:77-87.
63. Karlsen TA, Mirtaheri P, Shahdadfar A et al. Effect of three-dimensional culture and incubator gas concentration on phenotype and differentiation capability of human mesenchymal stem cells. J Cell Biochem 2011;112:684-693.